A host of researchers and companies across the globe are beginning to develop and market treatments targeting the aging process for the first time. Catch a mention of BioViva's work in the latest round up from Futurism.
Liz Parrish, CEO and Founder of BioViva, on Digital Health Today. Liz discusses the need for innovation solutions to aging and age-related disease, the importance of classifying aging as a disease, and BioViva's work developing gene and cell therapies to prevent, delay and reverse biological aging.
Liz spoke at L'Echappée Volée in May about BioViva's gene therapies and the need for innovative new solutions to the problem of aging and age-related disease. Catch a preview of the final talk which will be uploaded soon here. In this article Le Monde discusses the event, summarizing Liz's appearance and her receipt of BioViva's dual gene therapies.
Last week, Liz Parrish, BioViva's founder and CEO, sat down for a chat with the French publication Soon Soon Soon. During the interview Liz discussed about her vision of a world without suffering from disease, the technologies that will bring that world to fruition, and how BioViva will help.
Unfortunately, the interview and the Q&A is in French, but google translate does a pretty good job of translating it to English.
See the entire original article: Le monde de demain selon Liz Parrish, Fondatrice de BioViva
See the Google Translated English version of this article: The World of Tomorrow According to Liz Parrish, Founder of BioViva
Our CEO, Liz Parrish, spoke at the Wired Health conference in London last month. At the conference Liz spoke about how her son being diagnosed with Type 1 Diabetes was the motivation behind her researching gene therapy treatments for cures. She also spoke about how and why she tested gene therapies on herself. Finally, Liz discussed the importance of making gene therapy more widely available and how it could ‘cure’ the most prevalent disease of all; aging.
Wired Magazine has also written an article about Liz's talk -- Ageing is a disease. Gene therapy could be the 'cure'
ABOUT WIRED HEALTH 2017
Hundreds of healthcare, pharmaceutical and technology influencers and leaders met at the fifth annual WIRED Health event at 30 Euston Square, London on March 9. Discover some of the fascinating insights from the esteemed speakers here: http://wired.uk/O6xMxJ
ABOUT WIRED EVENTS
WIRED events shine a spotlight on the innovators, inventors and entrepreneurs who are changing our world for the better. Explore this channel for videos showing on-stage talks, behind-the-scenes action, exclusive interviews and performances from our roster of events. Join us as we uncover the most relevant, up-and-coming trends and meet the people building the future.
WIRED brings you the future as it happens - the people, the trends, the big ideas that will change our lives. An award-winning printed monthly and online publication. WIRED is an agenda-setting magazine offering brain food on a wide range of topics, from science, technology and business to pop-culture and politics.
BioViva and our CEO, Elizabeth Parrish, have been featured in the latest National Geographic article about the future of human evolution and how technology is accelerating it. We have chosen some of our favorite sections from the article but we recommend you read the whole thing. Please see the link to the article below.
"Like other species, we are the products of millions of years of adaptation. Now we're taking matters into our own hands."
'Last year the CEO of a company called BioViva claimed to have successfully reversed some of the effects of aging in her own body with injections from a gene therapy her company devised.'
'Aging reversal is just as augmentative as anything else we were talking about. Whatever drugs work to prevent Alzheimer’s will probably also work for cognitive enhancement, and they will work in adults almost by definition. DNA was left in the dust by cultural evolution”, George Church says, "but now it’s catching up.”
“We will transcend all of the limitations of our biology,” Kurzweil promised. “That is what it means to be human—to extend who we are.”
"....using genetically engineered viruses to force old mice to make more telomerase results in a longer lifespan with improved late-life health, without an increased risk of cancer.
Elizabeth Parrish, who is the CEO of BioViva – a company working to develop anti-ageing treatments – recently travelled to Colombia to receive gene therapy to extend her telomeres."
Elizabeth Parrish is the founder and CEO of BioViva, a biotech company which advocates gene and cell therapies to treat the diseases of aging. She is a major advocate of patient access to these revolutionary treatments, and became a test subject in September 2015 after receiving treatment for what she believes is the most common 'disease' - aging. To combat the process of aging, she subjected herself to two kinds of therapy - telomerase therapy and myostatin inhibitor.
"She (Liz Parrish) had spent more than two years studying literature, talking to experts, and had decided to undergo gene therapy – a treatment for genetic disorders that adds genes into cells to replace those that are faulty or absent."
“I was a person who quite honestly felt I had not really contributed that much to society and this was my opportunity to do so.”
“The company was built essentially to prove these therapies work or not,” Parrish says. “Remember BioViva is not a research organisation. We are taking things like gene therapies and using them like technology. We would like to create an open market where people have access to acquiring these technologies, much like you would acquire a cellphone or a computer.”
Liz Parrish, CEO of BioViva, speaks about helping people live longer healthier lives by using gene and cell therapies. Liz was speaking at Norways NRK TV show Trygdekontoret.
Last week WIRED Health gathered hundreds of leaders and influencers from across the globe in London to discuss the field of health innovation and technology. In addition to their long lists of honors and historic accolades, the unrivaled lineup of speakers brought an infectious enthusiasm for action in healthcare.
Elizabeth Parrish is CEO of BioViva, a Seattle-based biotech company working to develop treatments to slow the ageing process. In April, the company revealed that Parrish herself had undergone “the first gene therapy successful against human ageing”. The treatment, it claimed, had reversed the biological age of her immune cells by 20 years.
Elizabeth (Liz) Parrish is the CEO of BioViva, a biotechnology company that focuses on developing gene therapies, and other regenerative therapies, to intervene with human aging.Last September, Parrish added an interesting line to her job description: patient zero for two anti-aging therapies that the company is researching.